[Guideline on the assessment and management of cardiovascular risk in China]

Area of Science:

• Public Health
• Cardiology
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) represents a significant health burden and leading cause of mortality in China.
• Effective prevention and control strategies for CVD are crucial but remain challenging.
• Risk assessment and management of CVD risk factors are fundamental for primary prevention.

Purpose of the Study:

• To introduce a guideline for cardiovascular risk assessment in China.
• To outline procedures for 10-year and lifetime risk assessment.
• To provide principles for managing key CVD risk factors and promoting lifestyle changes.

Main Methods:

• The guideline synthesizes global observational and interventional evidence, alongside Chinese population studies.
• It details methodologies for cardiovascular risk assessment, including risk stratification.
• It incorporates recommendations for therapeutic lifestyle changes and management of blood pressure, lipids, and glucose.

Main Results:

• The guideline establishes a systematic approach to cardiovascular risk assessment in China.
• It emphasizes the application of digital tools (web-based and mobile) for risk assessment.
• It provides targeted strategies for managing modifiable CVD risk factors.

Conclusions:

• Implementation of this guideline is expected to enhance CVD risk assessment and factor management.
• It aims to promote both individualized and community-based CVD prevention strategies in China.
• The guideline serves as a vital tool for reducing the burden of CVD in the Chinese population.